Spanish Consensus Document on the Treatment Algorithm for Rosacea
Actas Dermosifiliogr (Engl Ed). 2019 Sep;110(7):533-545.
doi: 10.1016/j.ad.2019.01.001.
Epub 2019 Mar 2.
[Article in
English,
Spanish]
Authors
M Salleras
1
, M Alegre
2
, V Alonso-Usero
3
, P Boixeda
4
, J Domínguez-Silva
5
, J Fernández-Herrera
6
, X García-Navarro
7
, N Jiménez
4
, M Llamas
6
, C Nadal
8
, J Del Pozo-Losada
9
, I Querol
10
, I Salgüero
11
, M Schaller
12
, J Soto de Delás
13
Affiliations
- 1 Servicio de Dermatología, Hospital Universitario Sagrado Corazón, Barcelona, España. Electronic address: msalleras@quironsalud.es.
- 2 Servicio de Dermatología, Hospital Plató, Barcelona, España.
- 3 Servicio de Dermatología, Hospital Nisa 9 de Octubre, Valencia, España.
- 4 Sección de Dermatología, Hospital Ramón y Cajal, Madrid, España.
- 5 Servicio de Dermatología, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, España.
- 6 Sección de Dermatología, Hospital de La Princesa, Madrid, España.
- 7 Servicio de Dermatología, Consorci Sanitari del Garraf, Barcelona, España.
- 8 Servicio de Dermatología, Hospital Son Llatzer, Palma de Mallorca, España.
- 9 Servicio de Dermatología, Hospital Universitario A Coruña, La Coruña, España.
- 10 Universidad de Zaragoza, Zaragoza, España.
- 11 Servicio de Dermatología, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, España.
- 12 Departamento de Dermatología, Universidad de Klinikum, Tubinga, Alemania.
- 13 Servicio de Dermatología, Policlínica Gipuzkoa, San Sebastián, España.
Abstract
Recent scientific evidence and the incorporation of new drugs into the therapeutic arsenal against rosacea have made it necessary to review and update treatment criteria and strategies. To this end, a panel of 15 dermatologists, all experts in rosacea, was formed to share experiences and discuss treatment options, response criteria, and changes to treatment. Based on a critical review of the literature and a discussion of the routine practices of Spanish dermatologists, the panel proposed and debated different options, with consideration of the experience of professionals and the preferences of patients or equality criteria. Following validation of the proposals, the final recommendations were formulated and, together with the evidence from the main international guidelines and studies, used to produce this consensus document. The goal of this consensus document is to provide dermatologists with practical recommendations for the management of rosacea.
Keywords:
Brimonidina; Brimonidine; Doxiciclina; Doxycycline; Fuentes de luz; Isotretinoin; Isotretinoína; Ivermectin; Ivermectina; Light sources; Metronidazol; Metronidazole; Rosacea; Rosácea.
Copyright © 2019 AEDV. Publicado por Elsevier España, S.L.U. All rights reserved.
Publication types
-
Consensus Development Conference
-
Review
MeSH terms
-
Algorithms*
-
Anti-Bacterial Agents / therapeutic use
-
Brimonidine Tartrate / therapeutic use
-
Consensus*
-
Delphi Technique
-
Doxycycline / therapeutic use
-
Humans
-
Laser Therapy
-
Metronidazole / therapeutic use
-
Practice Guidelines as Topic
-
Quality of Life
-
Rosacea / classification
-
Rosacea / drug therapy
-
Rosacea / therapy*
Substances
-
Anti-Bacterial Agents
-
Metronidazole
-
Brimonidine Tartrate
-
Doxycycline